Literature DB >> 19687432

Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.

Benjamin D Korman1, Kenneth L Tyler, Neil J Korman.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19687432     DOI: 10.1001/archdermatol.2009.175

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  21 in total

1.  Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases.

Authors:  A Bharat; F Xie; J W Baddley; T Beukelman; L Chen; L Calabrese; E Delzell; C G Grijalva; N M Patkar; K Saag; K L Winthrop; J R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

Review 2.  Assessing long-term drug safety: lessons (re) learned from raptiva.

Authors:  Nicole M Seminara; Joel M Gelfand
Journal:  Semin Cutan Med Surg       Date:  2010-03

Review 3.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 4.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

5.  Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Authors:  Andrew M Posselt; Gregory L Szot; Lynda A Frassetto; Umesh Masharani; Mehdi Tavakol; Raj Amin; Joan McElroy; Marissa D Ramos; Robert K Kerlan; Lawrence Fong; Flavio Vincenti; Jeffrey A Bluestone; Peter G Stock
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

6.  JC virus granule cell neuronopathy is associated with VP1 C terminus mutants.

Authors:  Xin Dang; Jose E Vidal; Augusto C Penalva de Oliveira; David M Simpson; Susan Morgello; Jonathan H Hecht; Long H Ngo; Igor J Koralnik
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

Review 7.  Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents.

Authors:  Wolfgang Weger
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 8.  Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.

Authors:  Fariha Zaheer; Joseph R Berger
Journal:  Ther Adv Drug Saf       Date:  2012-10

Review 9.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

10.  A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes.

Authors:  S Moassesfar; U Masharani; L A Frassetto; G L Szot; M Tavakol; P G Stock; A M Posselt
Journal:  Am J Transplant       Date:  2015-11-23       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.